Texan Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Texan Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$300K	Hold	4,900	–	–	0.19%	89
2017 Q3	$312K	Hold	4,900	–	–	0.21%	86
2017 Q2	$273K	Sell	4,900 -46,082	-90%	-$2.51M	0.18%	89
2017 Q1	$2.77M	Hold	50,982	–	–	1.26%	27
2016 Q4	$2.98M	Sell	50,982 -36,218	-42%	-$1.98M	1.39%	22
2016 Q3	$4.7M	Sell	87,200 -4,585	-5%	-$295K	2.22%	5
2016 Q2	$6.75M	Sell	91,785 -899	-1%	-$63.5K	3.1%	3
2016 Q1	$5.9M	Sell	92,684 -2,092	-2%	-$132K	2.76%	5
2015 Q4	$6.52M	Sell	94,776 -1,415	-1%	-$93.5K	2.92%	3
2015 Q3	$5.69M	Sell	96,191 -475	-0.5%	-$30.1K	2.51%	4
2015 Q2	$6.43M	Buy	96,666 +46,233	+92%	+$3.05M	2.6%	6
2015 Q1	$3.25M	Sell	50,433 -10,627	-17%	-$665K	1.78%	13
2014 Q4	$3.6M	Buy	61,060 +1,600	+3%	+$90.2K	1.59%	17
2014 Q3	$3.04M	Buy	59,460 +2,400	+4%	+$120K	1.28%	20
2014 Q2	$2.77M	Buy	57,060 +49,360	+641%	+$2.43M	1.2%	21
2014 Q1	$400K	Hold	7,700	–	–	0.18%	113
2013 Q4	$409K	Hold	7,700	–	–	0.21%	105
2013 Q3	$356K	Hold	7,700	–	–	0.17%	122
2013 Q2	$344K	Buy	+7,700	New	+$334K	0.17%	118

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Texan Capital Management's BMY Position: Q4 2017 in Review

Texan Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q4 2017 at 4,900 shares worth $300K. The position accounts for 0.19% of the portfolio, ranked #89.

Texan Capital Management first reported a position in BMY in Q2 2013 and has held it in 19 quarters since. The position peaked at $6.75M in Q2 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Texan Capital Management held 4,900 shares of Bristol-Myers Squibb worth $300K as of Q4 2017.
Texan Capital Management left its Bristol-Myers Squibb share count unchanged in Q4 2017.
Bristol-Myers Squibb made up 0.19% of Texan Capital Management's portfolio in Q4 2017, its #89 holding.
Texan Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 19 quarters since.
Texan Capital Management's Bristol-Myers Squibb position peaked at $6.75M in Q2 2016.
1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Texan Capital Management's 13F filing for Q4 2017, filed 2 Feb 2018.